Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Published in J Am Heart Assoc on August 15, 2020
1: Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.
2: Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway.
3: Section of Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Norway.
4: Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden.
5: Uppsala Clinical Research Center Uppsala University Uppsala Sweden.
6: Department of Neurology Oslo University Hospital Rikshospitalet Oslo Norway.
7: Division of Cardiovascular Health and Disease Heart, Lung and Vascular Institute Academic Health Center Cincinnati OH.
8: AstraZeneca Research and Development Gothenburg Sweden.
9: Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield United Kingdom.
10: Department of Cardiology Stavanger University Hospital Stavanger Norway.
11: Drammen Heart Center Drammen Norway.
12: Section of Clinical Immunology and Infectious Diseases Oslo University Hospital Rikshospitalet Oslo Norway.
13: K.G. Jebsen TREC The Faculty of Health Sciences The Arctic University of Tromsø Tromsø Norway.